INS and Hyperglycemia: Less commonly, patients experienced infusion site reactions, hyperglycemia, increased insulin requirements, gastrointestinal distress, headaches, hearing loss, tinnitus, dizziness, urinary tract infections (UTIs), weight changes, and altered appetite.